Polaris Market Research releases its new research report on the Immuno-Oncology (IO) market, which provides comprehensive insight into the current market landscape and future outlook. It discusses all the major forces that can help drive growth in the market. This report studies the effect of rising demand, technology, applications, investments, and competition. It offers a comprehensive...

Market Overview Polaris Market Research’s latest research report, titled Oncology Information Systems Market, offers a comprehensive and data-driven analysis of the market landscape. Designed for decision-makers, strategists, and industry participants, this in-depth study offers critical insights into current trends, market dynamics, competitive strategies, and growth projections....

Valued at USD 18.82 billion in 2025, the prostate cancer treatment market is projected to reach USD 20.83 billion in 2026 and USD 47.78 billion by 2034, growing at a CAGR of 10.9% during the forecast period 2026–2034. Active participants include AbbVie Inc., Accord Healthcare, Amgen Inc., Astellas Pharma Inc., AstraZeneca Plc, Bayer AG, Dendreon Pharmaceuticals LLC, Ferring...

The latest business intelligence report released by Polaris Market Research on Radiation Oncology Market Share, Size, Trends, Industry Analysis Report, By Type (External Beam Radiation Therapy [EBRT], Internal Beam Radiation Therapy [IBRT]); By Technology (External Beam Radiation Therapy, Brachytherapy); By Application; By Region; Segment Forecast, 2021 - 2028. It covers the in-depth...

The latest business intelligence report released by Polaris Market Research on Radiation Oncology Market Share, Size, Trends, Industry Analysis Report, By Type (External Beam Radiation Therapy [EBRT], Internal Beam Radiation Therapy [IBRT]); By Technology (External Beam Radiation Therapy, Brachytherapy); By Application; By Region; Segment Forecast, 2021 - 2028. It covers the in-depth...

The Non-Small Cell Lung Cancer ($\text{NSCLC}$) Market is undergoing a profound shift, moving away from generalized chemotherapy regimens toward highly personalized treatment strategies, driven by the discovery of actionable molecular targets. $\text{NSCLC}$ is the most common form of lung cancer, and its high mortality rate drives intensive research into more effective therapeutic...

The Non-Small Cell Lung Cancer ($\text{NSCLC}$) Market is undergoing a profound shift, moving away from generalized chemotherapy regimens toward highly personalized treatment strategies, driven by the discovery of actionable molecular targets. $\text{NSCLC}$ is the most common form of lung cancer, and its high mortality rate drives intensive research into more effective therapeutic...

Multiple Myeloma Therapeutics Market Growing at 6.1% CAGR According to Straits Research, the global Multiple Myeloma Therapeutics Market was valued at USD 23.27 Billion in 2021 and is projected to grow from USD XX Billion in 2022 to USD 39.65 Billion by 2030, reflecting a CAGR of 6.1% over the forecast...

Global Radiopharmaceutical Market Growing at 9.3% CAGR | Industry Forecast 2024–2032 According to Straits Research, the global Radiopharmaceutical Market was valued at USD XX Billion in 2023 and is projected to grow from USD XX Billion in 2024 to USD XX Billion by 2032, exhibiting a CAGR of 9.3% during...